Michael Giladi

8.1k citations
126 papers · 6.5k · 1 hit paper · h-index 42

Impact in

  • Parasitology top 0.5%
    • Bartonella species infections research
    • Vector-borne infectious diseases
    • Viral Infections and Vectors
    • Antifungal resistance and susceptibility

Papers in

    • Bartonella species infections research 36
    • Vector-borne infectious diseases 13
    • Viral Infections and Vectors 14
    • Antifungal resistance and susceptibility 12

Michael Giladi

123 papers receiving 6.0k citations

Michael Giladi's Hit Papers

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial 2015 · 777 citations
7770+3+7Years since publication250500750

Peers

Michael Giladi
Comparison fields: 5 of 147
  • Parasitology 1.2k
  • Infectious Diseases 2.5k
  • Orthopedics and Sports Medicine 918
  • Applied Microbiology and Biotechnology 207
  • Occupational Therapy 439
Replace Ken B. Waites with:
Ken B. Waites United States
Alan L. Bisno United States
Michael D. Nissen Australia
Tristan Ferry France
Richard D. Meyer United States
Joseph G. McCormack Australia
Andréas Stein France
Paul G. Auwaerter United States
C. Anthony Hart United Kingdom
John W. Sanders United States
Michael Giladi relative to Ken B. Waites United States Ken B. Waites's profile →
Citations per field
00.5×10×20×26.2×
Ken B. Waites · 1×
Citations per year

Countries citing papers authored by Michael Giladi

Since Specialization
Citations

This map shows the geographic impact of Michael Giladi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Giladi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Giladi more than expected).

Fields of papers citing papers by Michael Giladi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Giladi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Giladi. The network helps show where Michael Giladi may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Giladi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Giladi Line = papers co-authored together Michael Giladi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Hit paper breakdown →
2015777
2 1985287
3 2006281
4 2001267
5 1989213
6 2001213
7 1991179
8 2002161
9 2001159
10 2012151
11 2004148
12 1987130
13 1986129
14 2010123
15 2001118
16 1989108
17 1998108
18 1985107
19 1994105
20 200399

About Michael Giladi

Michael Giladi is a scholar working on Parasitology, Infectious Diseases, Epidemiology, Occupational Therapy and Orthopedics and Sports Medicine, having authored 126 papers that have together received 6.5k indexed citations. Recurring topics across this work include Bartonella species infections research (36 papers), Streptococcal Infections and Treatments (20 papers), Occupational Health and Performance (15 papers), Viral Infections and Vectors (14 papers), Bone fractures and treatments (13 papers), Vector-borne infectious diseases (13 papers), Antifungal resistance and susceptibility (12 papers) and Rabies epidemiology and control (10 papers). The work is most often cited by research in Parasitology (1.2k citations), Infectious Diseases (2.5k citations), Orthopedics and Sports Medicine (918 citations), Applied Microbiology and Biotechnology (207 citations) and Occupational Therapy (439 citations). Michael Giladi has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Charles Milgrom, Ariel Simkin, Yardena Siegman‐Igra, Michael D. Stein, Hanoch Kashtan, Boaz Avidor, Roland Chisin, R. Steinberg, Z. Aharonson and David Asa Schwartz. Their work appears in journals such as Clinical Infectious Diseases, Emerging infectious diseases, Journal of Clinical Microbiology, Clinical Orthopaedics and Related Research and Scandinavian Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact